Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia.

White, Brian S; Khan, Suleiman A; Mason, Mike J; Ammad-Ud-Din, Muhammad; Potdar, Swapnil; Malani, Disha; Kuusanmäki, Heikki; Druker, Brian J; Heckman, Caroline; Kallioniemi, Olli; Kurtz, Stephen E; Porkka, Kimmo; Tognon, Cristina E; Tyner, Jeffrey W; Aittokallio, Tero; Wennerberg, Krister; Guinney, Justin

White, Brian S; Khan, Suleiman A; Mason, Mike J; Ammad-Ud-Din, Muhammad; Potdar, Swapnil; Malani, Disha; Kuusanmäki, Heikki; Druker, Brian J; Heckman, Caroline; Kallioniemi, Olli; Kurtz, Stephen E; Porkka, Kimmo; Tognon, Cristina E; Tyner, Jeffrey W; Aittokallio, Tero; Wennerberg, Krister; Guinney, Justin.

Afiliación

White BS; Computational Oncology, Sage Bionetworks, Seattle, WA, USA. bstephenwhite@gmail.com.
Khan SA; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. bstephenwhite@gmail.com.
Mason MJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Ammad-Ud-Din M; Computational Oncology, Sage Bionetworks, Seattle, WA, USA.
Potdar S; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Malani D; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Kuusanmäki H; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Druker BJ; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Heckman C; Biotech Research & Innovation Centre (BRIC) and Novo Nordisk Foundation Center for Stem Cell Biology (DanStem), University of Copenhagen, Copenhagen, Denmark.
Kallioniemi O; Howard Hughes Medical Institute, Portland, OR, USA.
Kurtz SE; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Porkka K; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Tognon CE; Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
Tyner JW; Scilifelab, Karolinska Institute, Solna, Sweden.
Aittokallio T; Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Wennerberg K; HUS Comprehensive Cancer Center, Hematology Research Unit Helsinki and iCAN Digital Precision Cancer Center Medicine Flagship, University of Helsinki, Helsinki, Finland.
Guinney J; Howard Hughes Medical Institute, Portland, OR, USA.

NPJ Precis Oncol ; 5(1): 71, 2021 Jul 23.

Article en En | MEDLINE | ID: mdl-34302041

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: NPJ Precis Oncol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google